Gen­mab to ap­peal Darza­lex ar­bi­tra­tion against J&J

Gen­mab is plan­ning to file an ap­peal less than a week af­ter los­ing an ar­bi­tra­tion against John­son & John­son again over their li­cens­ing pact for …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.